N-4-Boc-2-Piperazineacetic acid methyl ester, 97.0%, 250mg

Ethyl 5-Chloroimidazo[1,2-a]pyridine-2-carboxylate, 97.0%, 5g

2-Ethoxybenzhydrazide, 95.0%, 25g

4,6-Dibromoquinoline, 95.0%, 1g

(S)-1-(Pyrrolidin-3-yl)piperidine dihydrochloride, 95.0%, 250mg

2-amino-2-cyclopropylethan-1-ol hydrochloride, 95.0%, 100mg

1,3-Bis[5-(4-tert-butylphenyl)-2-[1,3,4]oxadiazolyl]benzene, 97%, 25g

NBD-Cl (=4-Chloro-7-nitro-2,1,3-benzoxadiazole) [for HPLC Labeling]>98.0%(T)1g

tert-Butyl 2-oxospiro[indoline-3,3'-pyrrolidine]-1'-carboxylate, 95.0%, 5g

1-(4-Methoxybenzyl)-1H-pyrazole-4-carbaldehyde, 95.0%, 250mg

N-Glycolyl-D-mannosamine Pentaacetate>93.0%(HPLC)100mg

(1-isopropyl-1H-imidazol-2-yl)methanol, 95.0%, 2.5g

5-Bromo-2-(trifluoromethoxy)benzonitrile, 95.0%, 25g